Checkpoint Capital L.P.
- SEC CIK
- 0001977548
- Latest filing
- Aug 14, 2026
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Nov 14, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 16
- 0 vs. Q2 2024
- Portfolio value
- $201.6M
- +$35.7M (+21.5%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ARGXArgenx SE | SPONSORED ADR | 92,500 | $50.1M | 24.9% | +10,350+12.6% | Added | History |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 663,381 | $34.8M | 17.2% | −258,719−28.1% | Reduced | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 1,504,307 | $27.2M | 13.5% | +629,307+71.9% | Added | History |
| CYTKCytokinetics Inc | COM NEW | 466,813 | $24.6M | 12.2% | +276,813+145.7% | Added | History |
| AXSMAxsome Therapeutics, Inc. | COM | 209,632 | $18.8M | 9.3% | −81,140−27.9% | Reduced | History |
| AVDLAvadel Pharmaceuticals PLC | Stock | 1,100,000 | $14.4M | 7.2% | −38,178−3.4% | Reduced | History |
| PTGXProtagonist Therapeutics, Inc | COM | 240,000 | $10.8M | 5.4% | −115,000−32.4% | Reduced | History |
| PLRXPliant Therapeutics, Inc. | COM | 380,000 | $4.26M | 2.1% | +147,800+63.7% | Added | History |
| TCRXTScan Therapeutics, Inc. | COM | 825,341 | $4.11M | 2.0% | +825,341 | New | History |
| ATYRaTYR PHARMA INC | COM NEW | 1,736,477 | $3.06M | 1.5% | −210,000−10.8% | Reduced | History |
| SLNOSoleno Therapeutics Inc | COM | 57,983 | $2.93M | 1.5% | +38,288+194.4% | Added | History |
| CDTXCidara Therapeutics, Inc. | COM NEW | 182,426 | $1.96M | 1.0% | +37,009+25.5% | Added | History |
| STOKStoke Therapeutics, Inc. | COM | 157,514 | $1.94M | 1.0% | +157,514 | New | History |
| IRONDisc Medicine, Inc. | COM | 25,543 | $1.26M | 0.6% | +25,543 | New | History |
| TRVITrevi Therapeutics, Inc. | COM | 250,000 | $835.0K | 0.4% | −250,089−50.0% | Reduced | History |
| ALLKAllakos Inc. | COM | 649,957 | $424.6K | 0.2% | 00.0% | Unchanged | History |
Sold out since Q2 2024 (3)
Positions held at the end of Q2 2024 that are gone from this filing.
| Security | Class | Shares in Q2 2024 | Value in Q2 2024 | % of portfolio in Q2 2024 | History |
|---|---|---|---|---|---|
| CORTCorcept Therapeutics Inc | COM | 244,750 | $7.95M | 4.8% | History |
| KYMRKymera Therapeutics, Inc. | COM | 82,000 | $2.45M | 1.5% | History |
| APLTApplied Therapeutics, Inc. | COM | 227,470 | $1.06M | 0.6% | History |